AGR2 overexpression in isogenic cancer cells can upregulate the proliferation biomarker Ki67 and the tumor modifier TSG101 resulting in p53 protein degradation (17) and AGR2 has extra-cellular oncogenic roles independent of its intra-cellular ER secretory activity (12). This evidence concerns the gene AGR2 and neoplasm.